Abstract | BACKGROUND: Skin injuries and the consequent loss of tissue integrity triggers a sequence of cellular and biochemical events that lead to a healed wound. Any failure during this rather sophisticated process may result in pathological scarring. METHODS: To evaluate the efficacy of topical verapamil as a modulator of the healing process, a group of five observers ( plastic surgeon, dermatologist, physiotherapist, biologist, and layman) analyzed pictures of 120 patients 3 months after abdominoplasty (60 patients) and mammoplasty (60 patients). Half of each group of patients used the topical verapamil scar modulator. Pictures were rated using the Stony Brook Scale. RESULTS: CONCLUSIONS: This is the first clinical trial that reports the use of topical verapamil as a modulator in the healing process in the postoperative period. Based on clinical results and on the high level of reliability and statistical significance, we concluded that verapamil at a concentration of 50 µM is an excellent choice as a scar modulator; its use avoids the development of keloids and hypertrophic scars after plastic surgery.
|
Authors | Ricardo Frota Boggio, Leonardo Frota Boggio, Bruno Luiz Galvão, Glaucia Maria Machado-Santelli |
Journal | Aesthetic plastic surgery
(Aesthetic Plast Surg)
Vol. 38
Issue 5
Pg. 968-75
(Oct 2014)
ISSN: 1432-5241 [Electronic] United States |
PMID | 25189298
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Calcium Channel Blockers
- Verapamil
|
Topics |
- Abdominoplasty
- Administration, Topical
- Adult
- Aged
- Calcium Channel Blockers
(administration & dosage)
- Cicatrix, Hypertrophic
(prevention & control)
- Humans
- Keloid
(prevention & control)
- Mammaplasty
- Middle Aged
- Verapamil
(administration & dosage)
- Wound Healing
(drug effects)
|